IFRX News - Candlesense

InflaRx Announces Participation in September Investor Conferences

JENA, Germany, Aug. 21, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today annou...

Conference

3 days ago

InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update

JENA, Germany, Aug. 07, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today annou...

How might the recent business update influence analyst sentiment and target price revisions for IFRX? What are the potential upside or downside risks highlighted in the management discussion that could impact the stock price? Did the company disclose any changes in its capital structure, such as share issuances, debt financing, or stock option exercises?

Earnings

17 days ago